🇺🇸 FDA
Patent

US 7671198

Process for preparing intermediates to 5-HT4 receptor agonist compounds

granted A61PA61P1/00A61P25/00

Quick answer

US patent 7671198 (Process for preparing intermediates to 5-HT4 receptor agonist compounds) held by Theravance, Inc. expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Mar 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61P, A61P1/00, A61P25/00